Home

Mottle Souligner pas cher ccne1 amplification Trêve de face culte

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition |  Nature
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition | Nature

CCNE1 copy-number gain and overexpression identify ovarian clear cell  carcinoma with a poor prognosis - Modern Pathology
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis - Modern Pathology

CCNE1 copy number is a biomarker for response to combination WEE1-ATR  inhibition in ovarian and endometrial cancer models
CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models

CCNE1 amplification among metastatic sites in patients with gynecologic  high-grade serous carcinoma - ScienceDirect
CCNE1 amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma - ScienceDirect

Adam Petrone¹, Elia Aguado-Fraile¹, Sunantha Sethuraman¹, Adrienne  Johnson¹, Ian Silverman¹, Gary Marshall¹, Jorge S. Rei
Adam Petrone¹, Elia Aguado-Fraile¹, Sunantha Sethuraman¹, Adrienne Johnson¹, Ian Silverman¹, Gary Marshall¹, Jorge S. Rei

CCNE1 amplification is associated with poor overall survival (n = 62,... |  Download Scientific Diagram
CCNE1 amplification is associated with poor overall survival (n = 62,... | Download Scientific Diagram

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition |  Nature
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition | Nature

CCNE1 amplification is associated with poor prognosis in patients with  triple negative breast cancer | BMC Cancer | Full Text
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer | BMC Cancer | Full Text

CCNE1-Amplified Cancers Targeted Through Synthetic Lethality Involving  PKMYT1 Kinase - Promega Connections
CCNE1-Amplified Cancers Targeted Through Synthetic Lethality Involving PKMYT1 Kinase - Promega Connections

Short Talk: Oncogenic CCNE1 Amplification Is Synthetic Lethal with PKMYT1  Kinase Inhibition - Keystone Symposia
Short Talk: Oncogenic CCNE1 Amplification Is Synthetic Lethal with PKMYT1 Kinase Inhibition - Keystone Symposia

CCNE1 amplification is associated with aggressive potential in endometrioid  endometrial carcinomas
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival  after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian  Cancer | PLOS ONE
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer | PLOS ONE

Functional characterization of the 19q12 amplicon in grade III breast  cancers | Breast Cancer Research | Full Text
Functional characterization of the 19q12 amplicon in grade III breast cancers | Breast Cancer Research | Full Text

Diagnostics | Free Full-Text | CCNE1 Amplification as a Predictive  Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
Diagnostics | Free Full-Text | CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition |  Nature
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition | Nature

Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and  therapeutic targets in: Endocrine-Related Cancer Volume 27 Issue 5 (2020)
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets in: Endocrine-Related Cancer Volume 27 Issue 5 (2020)

Cancers | Free Full-Text | Homologous Recombination Deficiency and Cyclin  E1 Amplification Are Correlated with Immune Cell Infiltration and Survival  in High-Grade Serous Ovarian Cancer
Cancers | Free Full-Text | Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer

Frontiers | Reversing Platinum Resistance in High-Grade Serous Ovarian  Carcinoma: Targeting BRCA and the Homologous Recombination System
Frontiers | Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System

Replication stress induced by CCNE1 overexpression creates a dependency on  XRCC2 at the replication fork | bioRxiv
Replication stress induced by CCNE1 overexpression creates a dependency on XRCC2 at the replication fork | bioRxiv

CCNE1 and BRD4 amplification and associations with cyclin E and BRD4... |  Download Scientific Diagram
CCNE1 and BRD4 amplification and associations with cyclin E and BRD4... | Download Scientific Diagram

PDF] Resistance to CDK2 Inhibitors Is Associated with Selection of  Polyploid Cells in CCNE1-Amplified Ovarian Cancer | Semantic Scholar
PDF] Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer | Semantic Scholar

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival  after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian  Cancer | PLOS ONE
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer | PLOS ONE